Global Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The global pharmaceuticals market had total revenues of $1,299.3 billion in 2022, representing a compound annual growth rate (CAGR) of 5.5% between 2017 and 2022.
0
The Asia-Pacific region acquired a 32.7% share of the global pharmaceuticals market in 2022. The growth in the global pharmaceuticals market is mainly due to the growth in emerging markets such as China and India. Emerging markets bring new opportunities to pharmaceutical companies.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the global
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Global pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the Global pharmaceuticals market by value in 2022?
What will be the size of the Global pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the Global pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the global's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What are the most recent market developments?

8 Company Profiles

8.1. Bayer AG
8.2. Novartis AG
8.3. Pfizer Inc.
8.4. Johnson & Johnson

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Global pharmaceuticals market value: $ billion, 2017-22
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Global pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Global pharmaceuticals market share: % share, by value, 2022
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Bayer AG: Key Employees Continued
Table 9: Novartis AG: key facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Novartis AG: Key Employees Continued
Table 13: Pfizer Inc.: key facts
Table 14: Pfizer Inc.: Annual Financial Ratios
Table 15: Pfizer Inc.: Key Employees
Table 16: Pfizer Inc.: Key Employees Continued
Table 17: Johnson & Johnson: key facts
Table 18: Johnson & Johnson: Annual Financial Ratios
Table 19: Johnson & Johnson: Key Employees
Table 20: Johnson & Johnson: Key Employees Continued
Table 21: Global exchange rate, 2018-22

List of Figures

Figure 1: Global pharmaceuticals market value: $ billion, 2017-22
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Global pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the global pharmaceuticals market, 2022
Figure 5: Drivers of buyer power in the global pharmaceuticals market, 2022
Figure 6: Drivers of supplier power in the global pharmaceuticals market, 2022
Figure 7: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2022
Figure 8: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2022
Figure 9: Drivers of degree of rivalry in the global pharmaceuticals market, 2022
Figure 10: Global pharmaceuticals market share: % share, by value, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Bayer AG
Novartis AG
Pfizer Inc.
Johnson & Johnson

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€343EUR$350USD£286GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€515EUR$525USD£428GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€687EUR$700USD£571GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Ethical Pharmaceuticals Global Market Report 2024

Specialty Pharmaceuticals Market 2024-2028

Bulk Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

Pharmerging Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030